According to Taysha Gene Therapies's latest financial reports the company's current earnings (TTM) are -$0.12 B. In 2022 the company made an earning of -$0.17 B an increase over its 2021 earnings that were of -$0.18 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.12 B | -33.06% |
2022 | -$0.17 B | -4.51% |
2021 | -$0.18 B | 190.82% |
2020 | -$60.02 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -0.70% | ๐บ๐ธ USA |